Christophe Moreno
Université libre de Bruxelles
281 Papers
1.9K Citations
Christophe Moreno is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 53, co-authored 259 publications. Previous affiliations of Christophe Moreno include Free University of Brussels & University of Toronto.
Chat about Author
Papers
Resistance patterns in patients with chronic hepatitis C genotype 4 infection and treatment outcome
Julia Dietz,Johannes Vermehren,Simone Susser,K.-H. Peiffer,Georgios Grammatikos,D. Perner,Beat Müllhaupt,Peter Buggisch,Jörg Petersen,JM Schattenberg,Peter R. Galle,J.-P. Chave,M. Kuhn,Reinhart Zachoval,Claus Niederau,J Schulze zur Wiesch,Christophe Moreno,Thomas Berg,Christoph P. Berg,S. Zeuzem,Christoph Sarrazin +20 more
3
PS-047-HSD17B13 loss of function variant protects from hepatocellular carcinoma developed on alcohol related liver disease
Jie Yang,Eric Trepo,Pierre Nahon,Christophe Moreno,Eric Letouzé,Sandrine Imbeaud,Thierry Gustot,Jacques Devière,Paulette Bioulac-Sage,Julien Calderaro,Nathalie Ganne,Alexis Laurent,Jean-Frédéric Blanc,Erwan Guyot,Angela Sutton,Marianne Ziol,Jessica Zucman-Rossi,Jean-Charles Nault +17 more
3
•Journal Article
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?
Hans Orlent,Hendrik Reynaert,Suzanne Bourgeois,Vinciane Dideberg,Michael Adler,Isabelle Colle,Stéphane De Maeght,Wim Laleman,Peter Michielsen,Christophe Moreno,Jean-Pierre Mulkay,Peter Stärkel,Jean Delwaide +12 more
TL;DR: The eventual role of the IL28B genotype in new therapeutic regimes with direct antiviral agents needs to be explored in the ongoing and future clinical studies with these agents.
2
Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.
Antoon Billiet,Frederik Temmerman,Walter Coudyzer,Natalie Van den Ende,Isabelle Colle,Sven Francque,S. De Maeght,F Janssens,Hans Orlent,D. Sprengers,Jean Delwaide,Sofie Decock,C De Vloo,Christophe Moreno,Hannah van Malenstein,Schalk Van der Merwe,Jef Verbeek,Frederik Nevens +17 more
TL;DR: In this paper , a five-year prospective multi-centric observational study in 21 hospitals in Belgium gathered a study population of 198 symptomatic polycystic liver disease (PLD) patients of whom the disease-specific symptom questionnaire PLD-complaint-specific assessment (POLCA) scores were calculated.
2
Prescription and efficacy of daclatasvir and sofosbuvir ± ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: The CMPASS-EU cohort study
Suzanne Bourgeois,Karel J. van Erpecum,Jean Delwaide,U Naumann,Stefan Christensen,Christophe Moreno,Anita Pathil,Emile Schippers,Nancy van Emmerik,Benoit Caritey,C. Fischer,Florence Mercier,Joerg Petersen +12 more
TL;DR: In this cohort, DCV+SOF±RBV was efficacious for HCV treatment across a range of subgroups and associated withQoL improvements, and Statistically significant improvements in all QoL outcomes were observed over 12 months of DCV-based treatments.
2